P 21 (10MG)
P21 is a synthetic peptide sequence originally developed to support research into cognitive function, neuronal health, and age‑related decline. It is widely…
Mechanism of Action
See published literature and COA for batch-specific analytical data. Research use only — not for human or veterinary administration.
Research Applications
- In vitro laboratory research
- Receptor and pathway assays
- Comparative peptide studies
Specifications
| appearance | See COA for lot-specific appearance and identity confirmation |
Reconstitution (Laboratory)
Reconstitute with bacteriostatic water under sterile laboratory conditions unless otherwise specified for your protocol.
Storage & Handling
Lyophilized: 2–8 °C long-term. Reconstituted: refrigerate at 2–8 °C. Protect from light.
Quality Assurance
Every lot undergoes independent third-party HPLC purity analysis, mass spectrometry identity confirmation, and endotoxin testing (<0.5 EU/mg). Certificate of Analysis (COA) is stored against the SKU lot number and available through your research account portal.
Sources & References
- 1.Kazim SF, et al. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease. Neurobiol Dis. 2014. · PubMed →
- 2.Bolognin S, et al. Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound. Neurobiol Aging. 2014. · PubMed →
- 3.Baazaoui N, et al. Alzheimer's Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound. Biomolecules. 2022. · PubMed →